CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data
-
May 29 2018
-
-
Source: BMC Public Health. 18.
[PDF-898.76 KB]
Details:
-
Alternative Title:BMC Public Health
-
Personal Author:
-
Description:Background
Factors that affect latent tuberculosis infection (LTBI) treatment completion in the US have not been well studied beyond public health settings. This gap was highlighted by recent health insurance-related regulatory changes that are likely to increase LTBI treatment by private sector healthcare providers. We analyzed LTBI treatment completion in the private healthcare setting to facilitate planning around this important opportunity for tuberculosis (TB) control in the US.
Methods
We analyzed a national sample of commercial insurance medical and pharmacy claims data for people ages 0 to 64 years who initiated daily dose isoniazid treatment between July 2011 and March 2014 and who had complete data. All individuals resided in the US. Factors associated with treatment completion were examined using multivariable generalized ordered logit models and bivariate Kruskal-Wallis tests or Spearman correlations.
Results
We identified 1072 individuals with complete data who initiated isoniazid LTBI treatment. Treatment completion was significantly associated with less restrictive health insurance, age < 15 years, patient location, use of interferon-gamma release assays, non-poverty, HIV diagnosis, immunosuppressive drug therapy, and higher cumulative counts of clinical risk factors.
Conclusions
Private sector healthcare claims data provide insights into LTBI treatment completion patterns and patient/provider behaviors. Such information is critical to understanding the opportunities and limitations of private healthcare in the US to support treatment completion as this sector’s role in protecting against and eliminating TB grows.
Electronic supplementary material
The online version of this article (10.1186/s12889-018-5578-3) contains supplementary material, which is available to authorized users.
-
Subjects:
-
Source:
-
Pubmed ID:29843664
-
Pubmed Central ID:PMC5975486
-
Document Type:
-
Volume:18
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
